Follow The Filings

VIR Vir Biotechnology Inc.

Health Care, filed as VIR BIOTECHNOLOGY INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q3 David Witzke sold out of Vir Biotechnology.

Who owns VIR

Sorted by value, long equity only, as of 2026 Q3.

History
David Witzke, Avidity Partners Management exited 2026 Q3 Last 2026 Q2 0.85% Exit −0.85% 519,300 $5.3M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by VIR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VIR insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $7M sold by 6 insiders under 10b5-1 plans
  1. Vanina De Verneuil EVP, General Counsel, Corp Sec
    Planned sale
    $27K 2,407 shares at $11.10 2.1% of stake
    Traded Nov 3 Filed Nov 4
  2. Janet Napolitano Director
    Planned sale
    $30K 3,200 shares at $9.45 13% of stake
    Traded Jun 1 Filed Jun 2
  3. Brent Sabatini SVP, Chief Accounting Officer
    Planned sale
    $3,582 379 shares at $9.45 0.6% of stake
    Traded Jun 1 Filed Jun 2
  4. Vicki L. Sato Director
    Planned sale
    $221K 22,000 shares at $10.05 2% of stake
    Traded May 1 Filed May 4
  5. Vicki L. Sato Director
    Planned sale
    $200K 22,000 shares at $9.07 2% of stake
    Traded Apr 1 Filed Apr 2
  6. Brent Sabatini SVP, Chief Accounting Officer
    Planned sale
    $70K 7,711 shares at $9.12 11% of stake
    Traded Mar 23 Filed Mar 24
  7. Vicki L. Sato Director
    Planned sale
    $209K 22,000 shares at $9.51 1.9% of stake
    Traded Mar 2 Filed Mar 3
  8. Vicki L. Sato Director
    Planned sale
    $413K 42,377 shares at $9.75 3.6% of stake
    Traded Feb 24 Filed Feb 26
  9. Mark Eisner EVP and Chief Medical Officer
    Planned sale
    $19K 1,889 shares at $9.82 1.2% of stake
    Traded Feb 25 Filed Feb 26
  10. Vanina De Verneuil EVP, General Counsel, Corp Sec
    Planned sale
    $135K 13,700 shares at $9.82 11% of stake
    Traded Feb 25 Filed Feb 26
  11. Vicki L. Sato Director
    Planned sale
    $170K 22,000 shares at $7.71 1.9% of stake
    Traded Feb 2 Filed Feb 3
  12. Vicki L. Sato Director
    Planned sale
    $130K 22,000 shares at $5.93 1.9% of stake
    Traded Jan 2 Filed Jan 5
  13. SVF Endurance (Cayman) Ltd 10% owner, +2 joint filers
    Planned sale
    $1.1M 191,854 shares at $5.98 1.4% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  14. Vicki L. Sato Director
    Planned sale
    $132K 22,000 shares at $6.00 1.8% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
  15. SVF Endurance (Cayman) Ltd 10% owner, +2 joint filers
    Planned sale
    $1.2M 189,431 shares at $6.41 1.3% of stake
    Traded Nov 26–28 Filed Dec 1, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 13 sales to cover taxes, 6 other transactions, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
424B5
424B5
8-K 1.01,8.01,9.01
424B5
SCHEDULE 13G —
8-K 7.01,8.01,9.01
SCHEDULE 13D/A —
10-Q
8-K 2.02,9.01
8-K 5.02
SCHEDULE 13G/A —
8-K 3.02,8.01,9.01
8-K 8.01,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.02
8-K 5.02
8-K 5.02,5.07
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $74.2M $68.56M
Gross profit * — $73.36M $68.53M
Gross margin * — 98.9% 100.0%
Net income -$615.12M -$521.96M -$437.99M
Net margin * — -703.4% -638.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.59B $1.04B $0.514B
Total non-current assets * $330.83M $356.36M $488.74M
Total assets $1.92B $1.4B $1B
Total current liabilities $175.41M $119.66M $92.82M
Total non-current liabilities * $153.42M $128.77M $144.73M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$778.78M -$446.35M -$391.78M
Cash from investing $164.63M $499.37M $310.37M
Cash from financing $7.48M $4.39M $3.78M
Net change in cash -$606.68M $57.4M -$77.62M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf